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There is a need to identify cost-efficient practices in delivering health care.  
Aims 
To illustrate how cost-efficient practices can be identified and disseminated in treating thoracic 
empyema.  
Methods 
Data Envelopment Analysis (DEA) was used to identify the scope for reducing Length of Stay (LOS), 
and therefore costs, at inpatient spell level for thoracic empyema.  
Findings 
LOS reduction potential was identified representing about 50% of the recorded LOS. Significant 
differences in potential for LOS reduction were also found between consultant teams and between 
sources of patient admission.  
Conclusions 
DEA enables multiple conditioning factors affecting costs at inpatient spell level  to be taken into 
account simultaneously. It enables management to identify and disseminate best practice within its 
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- Identifying cost efficient practices in treating thoracic empyema 
- Assessing cost efficiency at inpatient spell level 
- Controlling for patient condition in predicting Length of Stay for thoracic empyema  
- Data Envelopment Analysis as an efficiency assessment method 
- Identifying benchmarks for cost efficiency in treating thoracic empyema 
 
Reflective questions 
1. How can we control for co-morbidities presenting on patient admission so as to 
predict the expected cost of treatment during an inpatient spell? 
2. How can we identify cost-efficient practices in delivering an inpatient spell for a 
given primary diagnosis? 
3. How can we identify benchmark inpatient spells from which best practice can be 







The healthcare industry is one of the largest in the world, using nearly 10% of global GDP. Due to an 
ageing population and increased prevalence of chronic diseases, costs and patient numbers in the 
healthcare sector continue to grow. The need for health care providers to operate more efficiently 
and optimize productivity is therefore very important. This paper reports on an approach to 
improving the cost-efficiency of inpatient health care delivery through a systematic identification 
and dissemination of best practice. The approach is demonstrated using data on inpatient spells for 
thoracic empyema or Pyothorax (henceforth for ease of reference  empyema) at a major UK 
Children’s  hospital.  
For clarity, an inpatient spell encompases the “continuous period of time spent as a patient within a 
hospital. This is as opposed to an episode, which is the “time spent under one consultant”. A spell 
therefore could potentially contain multiple episodes. The study focuses on spells rather than 
episodes so as to encompass the whole time they were under the supervision of the hospital.  
The approach developed will allow a hospital  to assess retrospectively  performance in terms of cost 
at the granular level of  inpatient spells. Our approach allows the determination of a summary figure 
of cost efficiency, expressed here in the form of potential reduction in the Length of Stay (LOS) of 
the spell. Further investigations  will then identify how factors such as admittance location, time to 
first operation, treatment consultant etc. affect cost efficiency. This will enable hospitals to identify 
and roll out  operating practices conducive to improving cost  efficiency while eliminating practices 





2. METHOD  
We illustrate the use  Data Envelopment Analysis (DEA) for the purpose at hand. We use DEA to 
identify benchmark inpatient spells in terms of shortest LOS, controlling for patient condition on 
admission. The benchmarks are in turn used to estimate the potential for LOS reduction in other spells. 
DEA is by now a well established method for comparative efficiency assessments. Its key advantages 
are that it can take into account multiple incommensurate outcome measures and set them against 
multiple incommensurate resource and contextual factors to derive measures of efficiency and 
productivity which can be used to manage performance. 
 The development of DEA was initiated  by (Charnes et al. 1978),  based on initial ideas by (Farrell 
1957). Since then DEA has become the method of choice for efficiency and productivity analysis 
especially so in complex contexts where multiple incommensurate inputs are used to secure multiple 
incommensurate outputs. It is especially useful in cases where no input or output market prices exist, 
yet efficient resource use is important (e.g. health, education, justice, policing etc.). In a survey of DEA 
applications covering the period 1978 to 2010 (Liu et al. 2013) list over 3100 papers where some real 
life application was embedded. The five top areas in terms of application were banking, agriculture, 
education, health care and transportation. An outline of DEA  can be found in the  Appendix. For a 
fuller coverage of DEA as a method see (Thanassoulis 2001).  
 
3. IMPLEMENTATION OF DEA ON THORACIC EMPYEMA DATA 
3.1 Conceptualisation of the Setting for the Analysis 
The assessment of cost efficiency or productivity of health service delivery has been criticized (e.g. 
(Hollingsworth, 2008) because at the aggregate level that it is normally conducted one cannot reflect 
accurately the multiplicity of differences between the individual patients which in turn bear on the 
costs of treatment. The best predictor of a patient’s treatment costs is the medical diagnosis for which 
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the particular inpatient admission has been made. The severity or the stage of the disease, the general 
health condition of the patient along with his/her gender and age can also impact the cost of 
treatment even after we control for primary medical diagnosis for the admission.  
With the foregoing in mind our unit of analysis was set at inpatient spell level when one of the first 
3 diagnoses was either Pyothorax with fistula or Pyothorax without fistula. It is noted that the 
hospital concerned used Pyothorax  for thoracic empyema.  Narrowing in this way the scope of the 
analysis to patient level and specific diagnoses enables us to control as far as possible for the exact 
medical condition or conditions which impact the costs of treatment during an inpatient spell. Then 
any variation in costs between inpatient spells would be attributable to clinical judgment  and other 
treatment features, the efficacy of which we aim to gauge. At  the time of writing reliable data on 
the true cost of treatment during an inpatient spell was not available to us. It is for this reason that 
we have opted to use length of stay (LOS) of the inpatient spell as a surrogate for the cost incurred 
during the spell, (for a similar approach see (Thanassoulis et al,  20016). This is under the implicit 
assumption that clinical outcomes have not been jeopardised through inappropriately short LOS. We 
return to this point later, after the initial assessment of cost efficiency. 
Thus the resulting setting for the analysis is one where we wish to ascertain the extent to which  the 
LOS of inpatient spells for empyema could have been shorter, if at all, controlling for the condition 
on admission of an  empyema patient. The key question is how to reflect the condition of the 
inpatient on admission.  This question was addressed by a combination of clinical judgment and 
statistical tests.  
Clinical judgement, constrained by the availability of data, led to the view that the following impact 
variation in  LOS of inpatient spells for empyema treatment: 
- “Exams” – This is the number of radiological investigations  conducted within the inpatient 
spell. Exams are taken as a surrogate marker for the health condition presented by the patient 
on admission.  
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- “Proc” – This is the number of procedures conducted. It is used as a surrogate for the  severity 
of the empyema condition. We have excluded from “Proc” computed tomography or 
radiology as they are recorded within radiology exams above. 
- “Diag” -  We  have used the number of  separate diagnoses as  comorbidities, affecting LOS; 
- Age of the child (categorised into babies <2 years, toddlers  2-4, child 4-10, teen over 11); 
- Gender of the patient. 
A regression analysis using data on 358 spells on the foregoing  variables concurs  with the clinical 
judgement that exams and number of diagnoses do impact LOS. Number of procedures was not 
significant in a strict statistical sense. However clinical judgement was to retain procedures as a 
potential explanatory  variable for LOS.  Gender was not found to be statistically significant in 
explaining LOS. Taking baby as the base case, age is not statistically significant either except for 
‘teen’ which arguably has explanatory power for LOS.  However, given the relatively low number of 
teen cases, clinical judgement was to assess any impact of teen age post the basic initial assessment 
of  LOS congruity with patient condition.   
Within the framework of a DEA model  we set observed LOS of each spell against the number of  
EXAMS, PROCEDURES and DIAGNOSES pertaining to the spell. The model was then solved  to 
determine a corresponding virtual or real benchmark inpatient spell for each real inpatient spell. 
Using benchmarks in this way we estimate the shortest LOS feasible for each real inpatient spell, 
when we control for patient condition on admission. The benchmark inpatient spells are also used ex 
post to compare case notes of spells to identify best practice conducive to shortening  LOS and 
therefore to improve cost efficiency.  The model  solved can be found in the Appendix. It was solved 
using commercial DEA software (www.deasoftware.co.uk). 
3.2 Data 
Data on empyema inpatient spells was provided by  a Children’s hospital. The data covered the 
period  2007 – 2016. Spells where the length of stay was 0 or 1 days were removed as relating to 
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outpatients. Spells where the Empyema diagnosis did not fall within their first 3 diagnoses were 
removed as Empyema would likely not have been a main reason for their spell in hospital. Finally, 
spells where the patient died were also  removed, as their LOS was right-censored while also spells 
with LOS> 1.96 standard deviations from the mean were removed as outliers. This process  left 358 
spells, with mean 11.12, standard deviation of 5.78 and median of 9 days. The bulk of the spells last 
between 8 and 10 days. However, there is also a strong positive skew with some spells lasting over a 
month even after excluding 8 outlier spells that lasted even longer than that. 
Figure 1 shows the numbers of exams, procures and diagnoses per spell.  Some 75% of spells have 7 
or fewer exams and this number drops to 5 in the case of procedures and diagnoses. However, the 
distribution is skewed and a minority of cases have as many as 34, 17 and 14 Exams, Procedures and 
diagnoses respectively. Thus a significant number of spells (top quartile) differ substantially from the 
rest of the spells on patient condition on admission.  
 





































Figure 2 shows the estimated scope for LOS reductions estimated.
 
Figure 2: Scope for LOS reductions. 
Some 50% of spells can shave off at least  64% of their spell duration.  The quarter of least ‘efficient’ 
spells can reduce their durations by at least 72%  and three quarters of spells can reduce their LOS 
by at least 54% of their original LOS. On the whole, the results taken at face value suggest  there is a  
remarkably large scope for the reduction of LOS. Aggregating potential savings in terms of LOS days 
across all 358 spells it is found that a total of 1952 days could have been saved which is  just under 
50% of the aggregate observed LOS days. Clearly the findings cannot be taken at face value as there 
may be factors affecting patient condition  that it has not been possible to capture appropriately in 
the model, including the specific impact each type of diagnosis, exam or preocedure may have had 
on the duration of an in-patient spell. Nevertheless the results do give a preliminary indication that 
there is a great deal of potentially unnecessary stay in hospital that is worth investigating further 
with a view to  eliminating it. 
One of the strengths of the DEA method used is that it yields the potential savings in LOS at spell 































This makes it possible for hospital management to reassess the findings at spell level for any 
shortcomings in the model. Where, however, no explanation in clinical terms can be found for LOS in 
excess of the shortest estimated feasible, lessons can be learned about treatment protocols 
conducive to LOS savings without detriment to clinical outcomes. The reassessment of findings at 
‘inefficient’ spell level againts its ‘efficient’ peers  (benchmarks) can be demonstrated using an 
example. 
Spell 648 is an example of an ‘inefficient’ spell. It had LOS of 19 days  which the DEA model  
estimated could be reduced  to  5 days. This is a drastic potential saving  and so it calls for a further 
clinical review of the case. The model estimated the potential reduction to a LOS  of 5 days  with 
reference to two ‘efficient peer’ benchmark spells: 581 and 499.  
Table 1 compares the  data of spell 648 with those of its benchmark efficient spells. 
Table 1:  Comparing inefficient spell 648 with benchmark spells 581 and 499 
 LOS 
(Days) 
EXAMS PROCEDURES DIAGNOSES 
Inefficient 
spell 648 
19 11 - Unspecified opening of chest, - 
Insertion of tube drain into pleural 
cavity and  








6 17 - Insertion of tube drain into pleural 
cavity,  
- Insertion of central venous 
catheter NEC,  
- Approach to organ under 
ultrasonic control,  
- Invasive ventilation and  
- Non-invasive ventilation NEC 
pyothorax 
without fistula 




4 3 - Thoracoscopic approach to 
thoracic cavity 
- NEC and Right sided operation 
pyothorax 
without fistula 
plus one more 
diagnosis  
As can be seen from the data in Table 1, on the face of it, the benchmark spells 581 and 499 relate to 
patients who were more ill than the patient relating to spell 648. Yet LOS at the benchmarks was far 
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shorter than it was in the case of spell 648. So the analysis  does indicate the need for a clinical 
review of the case notes to see how the significant differences in expected LOS at the 3 spells on 
Table 1 have occurred. Clearly in reality this cross examination of ‘inefficient’  and corresponding 
‘efficient peer’ spells needs to be extended to a significant number of cases to draw  reliable 
conclusions for treatment protocols conducive to shorter LOS. 
 
5. DISCUSSION  
Our aim in this paper is to illustrate how DEA can be a useful tool in identifying operating practices 
and treatment protocols conducive to shorter LOS and ultimately to cost savings.  One aspect which 
facilitates this process is that DEA  assessments are at spell level. This enables us to cluster the 
findings by a number of categorical  variables such as primary diagnosis, origin of admission, 
treatment team etc in order to investigate their impact on LOS and thereby any lessons that could 
be learned for improving cost efficiency. We illustrate the approach here using the following 
categorical variables for clustering the findings. 
5.1 Primary diagnosis 
We begin by clustering the efficiencies (i.e. fractions to which observed LOS levels can be reduced) 
by the patient’s primary diagnosis, ‘Pyothorax without fistula’ (J869), ‘Pyothorax with Fistula’ (J860) 
or ‘Other’. This leads to subsets of 266 ‘J869’ spells, 30 ‘J860’ spells and 62 ‘Other’ spells. It can be 
seen in Table 2 that the spells where the patient was initially diagnosed with J860 were on average 




Table 2: Mean fractions to which observed LOS can be reduced  
Primary Diagnosis 
J869 J860 Other 
0.56 0.48 0.56 
 
Statistical tests confirmed  that spells where the primary diagnosis is  ‘Pyothorax with Fistula’ (J860) 
have indeed larger scope to lower LOS  than the rest of the spells. It is noted that J860 is the more 
serious diagnosis and, all else being equal, would be expected to lead to a longer LOS. This does 
suggest that perhaps these spells should be assessed as a separate subset. However, on assessing 
Pyothorax with fistula spells separately only a handful of spells were found to have a significantly 
different efficiency rating to that obtained when all spells were assessed together. We would 
recommend that management retain as a basic case the original pooled assessment but in the case 
of inefficient spells with fistula also examine their efficiency  score from the second, within subset 
assessment, in case the with fistula diagnosis justifies  the longer than expected LOS.  
5.2 Time to first operation 
Clustering the findings by time to first operation (TTFO)  enables us to check whether it impacts the 
scope for reducing LOS. TTFO varied between 1 hour and 3 minutes at its shortest  and  17 days, 21 
hours and 27 minutes at its longest, though this range is based on only  70% of the spells for which 
the requisite TTFO existed. On average TTFO in this subset was a little under 2 days. There appears 
to be some indication that the longer TTFO the larger the scope for saving on LOS. However, the 
relationship is relatively weak. (The correlation between TTFO and scope for LOS reduction (as a 
factor of observed LOS)  was 0.138).  Thus a reduction in TTFO would in principle be conducive to 
shorter LOS though the scope for reduction from TTFO alone seems limited. 
5.3 Admittance location 
A further investigation was conducted to ascertain whether the source of admission of the patient 
had an effect on the scope for reduction in LOS.  The spells are separated into those admitted from 
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‘Residence’ (184 spells)  and ‘Other Hospital’.  It is found that  spells relating to those admitted from 
other hospital have scope to reduce observed LOS by about 43% compared to 47% for those 
admitted from Residence. This difference is statistically significant.  Moreover, it was found that 
there is also a statistically significant difference in the LOS itself between the two groups. Those 
admitted from residence have mean LOS of approximately 12 days compared to just over 10 days for 
those admitted from other hospitals. Thus for patients admitted from residence we have both longer 
LOS and higher scope for reduction of LOS. Closer investigation revealed that the shorter LOS for 
those admitted from another hospital  is probably because of shorter TTFO.  Those coming from a 
residence take nearly an extra day before having their first operation. 
This finding about TTFO led us to also investigate whether admitance location  impacts other 
treatments  within a spell.  Interestingly, the variation seen in LOS is replicated for exams, 
procedures and diagnoses as well. Those admitted from a residence have higher values for all three 
variables but not in a statistically significant manner. This may be as a result of some of the exams, 
procedures etc. occurring at the previous hospital, meaning they are no longer required in the 
hospital under investigation.  
From the managerial perspective therefore one finding to take away is to see how those admitted 
from their own residence can have their TTFO reduced so as to ultimately reduce LOS. 
5.4 Variation between treatment teams  
Each treatment team is led by a consultant.  Clustering the spell efficiencies by treatment team it is 
possible to see whether there are significant differences between teams in scope for LOS reduction. 
Such information can help management disseminate best practice across treatment  teams. The last 
column of Table 3  shows for each consultant team the mean efficiency of the spells handled by that 













C6064661 17 9.941 5.471 4.059 5.176 0.620 
C5188516 60 8.95 5.333 3.500 2.933 0.577 
C3260582 28 12.536 8.500 4.536 4.321 0.573 
C3402959 16 10.813 5.625 4.188 3.375 0.557 
C4319047 13 12.000 7.154 5.077 4.231 0.550 
C4567778 13 10.308 6.231 4.231 3.615 0.541 
C2822363 108 10.769 6.046 3.843 3.454 0.539 
C7018160 13 11.538 6.077 4.077 3.154 0.509 
C3290662 12 10.000 4.583 3.333 2.333 0.497 
 
There does appear to be a fairly substantial variation between consultants on mean efficient  LOS 
fraction, with the worst performer in terms of low efficient LOS being C3290662. This is despite 
dealing with spells with some of the lowest exams, procedures and diagnoses among the teams 
listed in Table 3.  Closer look at the cases showed they are mainly patients with Empyema without 
fistula as their primary diagnosis. So, on the face of it there is no obvious explanation for some of the 
long LOS levels  of this team both relative to other teams but also relative to their own shorter LOS 
spells. From the management perspective  the team may be able to benefit by re-examining their 
own practices across less and more efficient spells in terms of LOS as well as those  of  their efficient 
peer consultant teams. 
 
6. PRACTICE IMPLICATIONS 
The primary aim of this paper has been to demonstrate how DEA, a general purpose method for 
comparative efficiency assessments, can aid health care delivery managers to identify and 
disseminate good practice in order to improve cost efficiency. The key advantage of DEA is that it 
rests on a simple comparison of inpatient spells obviating the need for more sophisticated models 
where an algebraic  relationship needs to be postulated between LOS and factors driving it, a 
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relationship which runs the risk of being miss-specified. DEA can compare health delivery activities  
at a very  granular level, including that of an inpatient spell as illustrated here. This in turn makes it 
possible to reflect   very closely the condition of the patient, focusing as in this case, on one primary 
or a very few closely related primary diagnoses pertaining to the admission. Additional data on 
patient condition can be taken into account such as secondary diagnoses, perhaps prior admissions 
to hospital, durations of stay and any other factors that clinicians can identify as pertinent to the 
condition of the patient on admission.  Once the condition of the patient is captured the 
methodology enables the user to compare inpatient spells on costs (where available) or LOS (as a 
surrogate for cost). The comparison would identify any systemic inefficient practices since any 
variation in costs or LOS could no longer be attributed to patient condition which would have in 
large measure been controlled for. 
In our case the aim was to identify practices conducive to cost efficiency in the treatment of children 
under 16 for empyema. Pyothorax with fistula was found to have lower efficiency than Pyothorax 
without fistula. However, this lower efficiency may simply be the result of our model  being unable 
to account fully for patient condition on admission. Further investigation by management is needed. 
Another finding of interest was that admissions from residence tend to have more scope for LOS 
reduction than those from other hospitals. This merits investigation by management as to how the 
finding may be exploited to lead to shorter LOS.  
The granular level of the analysis  at patient-spell  level makes it possible for management and 
clinicians to verify the robustness of the findings by directly contrasting each case with a small 
number  of efficient peer spells. Contrasting  LOS inefficient with comparable LOS efficient spells  has 
the added advantage that it enables management to identify operating practices conducive to 
greater  cost efficiency.  
 There are, of course limitations to the analysis which further research should address: 
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- The use of simply the number of diagnoses/procedures/lab tests, is a crude measure for, 
respectively, complexity/seriousness/general health condition of the patient. This 
shortcoming can be addressed by clinical input, coupled with data analysis aimed at 
identifying perhaps a weighting structure so that secondary diagnoses accompanying a 
primary diagnosis can be reflected more appropriately for the condition of a patient on 
admission.  
 
- The analysis has tacitly assumed that clinical outcomes were ‘appropriate’ for patient 
condition on admission.  This assumption can be relaxed in one or both of the following ways. 
Prior to the assessment spells where clinical outcomes may have been below expectation can 
be removed from the data set to enable comparisons only of spells with appropriate clinical 
outcomes. In addition, post the assessment inefficient spells can be compared with efficient 
peers which have at least as good clinical outcomes as the inefficient spell concerned. 
 
- For the comparisons between consultant teams, the sample size for most teams was fairly 
small in our case. This makes any definitive conclusions about consultant teams hard to justify. 
Larger samples per consultant team are needed to make findings at consultant team more 
reliable. Indeed given large enough numbers of spells per consultant team would enable 
assessments within consultant team and across all consultants to better isolate good and poor 
consultant team effects.  
 
By using methods such as that in this paper, management at a hospital would be able to identify 
spells where there is inefficiency. This could then help them to improve any processes followed, by 
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A1: A Graphical illustration of the principles of Data Envelopment Analysis (DEA) 
Figure A1, drawn on a simple production context where one resource is used to produce a single 
output, demonstrates the principles underlying DEA. We assume that we do not necessarily have 
constant returns to scale and so we cannot use a simple ratio of output to input to measure 
performance. To measure the efficiency of a unit we need to estimate either the minimum resource 
its output level would justify, or alternatively, the maximum output level its resource level could 
support. Then the input efficiency of the unit will be the ratio of the minimum input needed for its 
output level to its actual observed input level. The output efficiency of a unit is defined in an analogous 
manner. The two efficiency measures are not necessarily equal under non-constant returns to scale 
but they are so under an assumption of constant returns to scale.  
Figure A1 can now be used to illustrate the concepts underpinning a DEA assessment. At the centre 
of the approach is the assumption that averages of observed ‘units’ (in our case inpatient spells) are 
feasible in principle even if not actually observed in practice. For example all resource – output level 
combinations on the linear segment U1U2 in Figure A1 represent averages  of the  resource-output 
levels at U1 and U2  using different combinations of  weights that add up to 1  for at U1 and U2  
respectively.  The averages  can be of any or all  the observed units (spells), computed  using any set 
of weights attaching to the units which are non-negative but do add up to 1. If we proceed in this 
manner with the units in Figure A1 we can construct the ‘production space’ shaded. This contains all 
‘units’ feasible in principle even if not observed in reality. The boundary U1U2U3U6 of the production 
space corresponds to maximum output for any given level of resource and so it is referred to as the 





Figure A1: Measuring Efficiency by DEA- Graphical illustration  
 
Using the efficient boundary as a reference, information about the performance of all units can be 
derived. For example: 
1. The boundary units U1, U2, U3, and  U6 are relatively efficient in the sense that no 
other unit can offer better performance (e.g. lower level of resource) given the output 
level of each; 
2. Units U4 and U5 are relatively inefficient in the sense that in each case there exist 
other production points that offer better performance in terms of output per unit 
input. Measures of their input efficiency can be deduced by estimating the reduced 
resource level their output level would justify. For example, in the case of unit U5 the 
virtual unit at B shows the level of resource its output level would justify if it had been 
operating as efficiently as can be deduced from the performance of units U1 and U2 
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o The input level B in practice is seen as a target for unit U5 to reduce its input 
while maintaining its output, if it is to be efficient; 
o The units U1 and U2 are the closest units to its scale size (in terms of output level) 
and they are the benchmarks it could emulate in terms of operating practices in 
order to improve its performance. They are referred to as its efficient peers; 
o A measure of the efficiency of U5 is given by expressing the minimum resource 
level justified by its output level as a fraction of its actual resource level.  Thus 
the efficiency of U5 is AB/AU5;   (In an analogous manner the output efficiency of 
unit U5 can be obtained as CU5/CD by using as target output level at D justified 
by its resource level OC.) 
  A.2. The DEA model used 
Using the principles outlined above we constructed a Data Envelopment Analysis (DEA) to 
estimate the ‘efficient’  (i.e. shortest possible)  level of LOS for each spell.  Let   LOSj , EXAMSj, 
PROCj and DIAGj  be  the observed levels at spell j for exams, procedures and diagnoses 
respectively. The estimated lowest level for the LOS of some spell j0 is derived by solving the 
model in (M1) to determine the value for θ* which is the fraction to which its observed level 





θ*  = Min 𝜃𝜃 
Subject to: 




























 𝜆𝜆𝑗𝑗 ≥ 0                                               
                      
Model (M1) determines values of the weights λ,  adding up to 1, which can be used to 
create a virtual benchmark inpatient spell which will exhibit as low a proportion θ  of the 
observed LOSj0  of spell j0 as possible, while at the same time relating to at least the levels 
of  EXAMSj0, PROCj0  and DIAGj0  found at spell j0 .  
The model in (M1) was solved in respect of each empyema inpatient spell on which we 
had data.  
 
